NCT03816345 2026-04-13Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONational Cancer Institute (NCI)Phase 1 Recruiting300 enrolled
NCT07089771 2026-03-20Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance ColonoscopyRegion StockholmPhase NA Not yet recruiting480 enrolled